Duncan et al. also reported that ketamine-induced changes in BDNF levels are associated with its antidepressant efects and increased early sleep SWA during non-REM, as well as with the improvement in sleep quality in subjects with treatment-resistant depression (Duncan et al., 2017). Here, BDNF is linked to depressive disorder.